The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma

In this study we investigated the quality of life (QoL) of long-term survivors with follicular lymphoma (FL) after high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) using two standardized questionnaires. Altogether, 124 patients with FL were included in the study. A total of 6...

Full description

Saved in:
Bibliographic Details
Main Authors: Andresen, Silke (Author) , Brandt, Juliane (Author) , Dietrich, Sascha (Author) , Memmer, Marie-Luise (Author) , Ho, Anthony Dick (Author) , Witzens-Harig, Mathias (Author)
Format: Article (Journal)
Language:English
Published: 2012
In: Leukemia and lymphoma
Year: 2011, Volume: 53, Issue: 3, Pages: 386-393
ISSN:1029-2403
DOI:10.3109/10428194.2011.613132
Online Access:Verlag, Volltext: http://dx.doi.org/10.3109/10428194.2011.613132
Get full text
Author Notes:Silke Andresen, Juliane Brandt, Sascha Dietrich, Marie-Luise Memmer, Anthony D. Ho, Mathias Witzens-Harig

MARC

LEADER 00000caa a2200000 c 4500
001 1576216691
003 DE-627
005 20220814160328.0
007 cr uuu---uuuuu
008 180611r20122011xx |||||o 00| ||eng c
024 7 |a 10.3109/10428194.2011.613132  |2 doi 
035 |a (DE-627)1576216691 
035 |a (DE-576)506216691 
035 |a (DE-599)BSZ506216691 
035 |a (OCoLC)1341011350 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Andresen, Silke  |d 1980-  |e VerfasserIn  |0 (DE-588)1052243711  |0 (DE-627)788073249  |0 (DE-576)408002018  |4 aut 
245 1 4 |a The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma  |c Silke Andresen, Juliane Brandt, Sascha Dietrich, Marie-Luise Memmer, Anthony D. Ho, Mathias Witzens-Harig 
264 1 |c 2012 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online 10 October 2011 
500 |a Gesehen am 11.06.2018 
520 |a In this study we investigated the quality of life (QoL) of long-term survivors with follicular lymphoma (FL) after high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) using two standardized questionnaires. Altogether, 124 patients with FL were included in the study. A total of 63 patients received HDCT with ASCT, and this group was compared with 61 patients who were treated with rituximab and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy and supplementary radiation. In addition, the QoL of the patients was compared to the QoL of healthy people on the basis of two studies about the general health status of the German population. When the QoLs of the HDCT group and the conventional therapy group were compared, there was a tendency for better QoL in the HDCT group, maybe due to a higher proportion of patients in complete remission (CR) or a longer follow-up period in the HDCT group (8.5 years vs. 4.5 years in the conventional therapy group). In both the HDCT group and the conventional therapy group, the results of the questionnaires showed a reduced QoL compared to the healthy population. In this study, there was a tendency for better QoL in the HDCT group compared to the conventional therapy group. However, the negative impact of both HDCT and conventional therapy on the QoL of patients with follicular lymphoma should not be underestimated and should lead to the development of less toxic therapy strategies. 
534 |c 2011 
650 4 |a Adult 
650 4 |a Aged 
650 4 |a Antibodies, Monoclonal, Murine-Derived 
650 4 |a Antineoplastic Combined Chemotherapy Protocols 
650 4 |a Combined Modality Therapy 
650 4 |a Cyclophosphamide 
650 4 |a Doxorubicin 
650 4 |a Humans 
650 4 |a Lymphoma, Follicular 
650 4 |a Middle Aged 
650 4 |a Prednisone 
650 4 |a Quality of Life 
650 4 |a Radiotherapy, Adjuvant 
650 4 |a Rituximab 
650 4 |a Stem Cell Transplantation 
650 4 |a Surveys and Questionnaires 
650 4 |a Survivors 
650 4 |a Transplantation, Autologous 
650 4 |a Vincristine 
700 1 |a Brandt, Juliane  |d 1984-  |e VerfasserIn  |0 (DE-588)1035609851  |0 (DE-627)748781188  |0 (DE-576)38337863X  |4 aut 
700 1 |a Dietrich, Sascha  |d 1979-  |e VerfasserIn  |0 (DE-588)136406300  |0 (DE-627)694354635  |0 (DE-576)301003408  |4 aut 
700 1 |a Memmer, Marie-Luise  |e VerfasserIn  |0 (DE-588)1050735013  |0 (DE-627)784807957  |0 (DE-576)404984576  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Witzens-Harig, Mathias  |e VerfasserIn  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia and lymphoma  |d London [u.a.] : Taylor & Francis Group, 1989  |g 53(2012), 3, Seite 386-393  |h Online-Ressource  |w (DE-627)324746237  |w (DE-600)2030637-4  |w (DE-576)099718170  |x 1029-2403  |7 nnas  |a The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma 
773 1 8 |g volume:53  |g year:2012  |g number:3  |g pages:386-393  |g extent:8  |a The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma 
856 4 0 |u http://dx.doi.org/10.3109/10428194.2011.613132  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20180611 
993 |a Article 
994 |a 2012 
998 |g 1050736516  |a Witzens-Harig, Mathias  |m 1050736516:Witzens-Harig, Mathias  |d 910000  |d 910100  |e 910000PW1050736516  |e 910100PW1050736516  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1050735013  |a Memmer, Marie-Luise  |m 1050735013:Memmer, Marie-Luise  |d 910000  |d 910100  |e 910000PM1050735013  |e 910100PM1050735013  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 136406300  |a Dietrich, Sascha  |m 136406300:Dietrich, Sascha  |d 910000  |d 910100  |e 910000PD136406300  |e 910100PD136406300  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1035609851  |a Brandt, Juliane  |m 1035609851:Brandt, Juliane  |d 910000  |d 910100  |e 910000PB1035609851  |e 910100PB1035609851  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1052243711  |a Andresen, Silke  |m 1052243711:Andresen, Silke  |d 910000  |d 910100  |e 910000PA1052243711  |e 910100PA1052243711  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1576216691  |e 3012320296 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","family":"Andresen","given":"Silke","role":"aut","display":"Andresen, Silke"},{"role":"aut","display":"Brandt, Juliane","given":"Juliane","roleDisplay":"VerfasserIn","family":"Brandt"},{"given":"Sascha","display":"Dietrich, Sascha","role":"aut","family":"Dietrich","roleDisplay":"VerfasserIn"},{"given":"Marie-Luise","display":"Memmer, Marie-Luise","role":"aut","family":"Memmer","roleDisplay":"VerfasserIn"},{"family":"Ho","roleDisplay":"VerfasserIn","given":"Anthony Dick","display":"Ho, Anthony Dick","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Witzens-Harig","given":"Mathias","display":"Witzens-Harig, Mathias","role":"aut"}],"name":{"displayForm":["Silke Andresen, Juliane Brandt, Sascha Dietrich, Marie-Luise Memmer, Anthony D. Ho, Mathias Witzens-Harig"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"part":{"pages":"386-393","extent":"8","year":"2012","volume":"53","issue":"3","text":"53(2012), 3, Seite 386-393"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedKey":"1989","publisherPlace":"London [u.a.] ; London [u.a.]","dateIssuedDisp":"1989-"}],"title":[{"title_sort":"Leukemia and lymphoma","title":"Leukemia and lymphoma"}],"id":{"eki":["324746237"],"zdb":["2030637-4"],"issn":["1029-2403"]},"disp":"The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphomaLeukemia and lymphoma","note":["Gesehen am 08.09.15"],"pubHistory":["1.1989/90 -"],"recId":"324746237"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"id":{"doi":["10.3109/10428194.2011.613132"],"eki":["1576216691"]},"title":[{"title":"The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma","title_sort":"impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma"}],"recId":"1576216691","note":["Published online 10 October 2011","Gesehen am 11.06.2018"]} 
SRT |a ANDRESENSIIMPACTOFHI2012